ACUR

Acura Pharmaceuticals, Inc.
OTC Markets OTCPKUSDEQUITY Healthcare DELAYED
Last price
0.00
■ 0.00 (0.00%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
0.00
Prev close
0.00
Day high
0.00
Day low
0.00
Volume
400
Market cap
$6.60K
P/E (TTM)
52W range
0.00 – 0.01

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
0.00% +1.4%
1M
-66.67% -70.4%
3M
-50.00% -53.1%
6M
-80.00% -91.1%
YTD
-80.00% -92.3%
1Y
-66.67% -86.7%
3Y
-75.00% -149.2%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on ACUR open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
1.12M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Jan 2, 26
SKELLY WILLIAM G
Director
50.00K Direct
Jan 2, 26
ROSS GEORGE K
Director
50.00K Direct
Jan 2, 26
THANGARAJ IMMANUEL
Director
50.00K Direct
Jan 2, 25
SKELLY WILLIAM G
Director
50.00K Direct
Jan 2, 25
ROSS GEORGE K
Director
50.00K Direct
Jan 2, 25
THANGARAJ IMMANUEL
Director
50.00K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

3 reporting
NameRelationShares heldLatest
ROSS GEORGE K
Director 595.90K Conversion of Exercise of derivative security
SKELLY WILLIAM G
Director 675.99K Conversion of Exercise of derivative security
THANGARAJ IMMANUEL
Director 2.50M Conversion of Exercise of derivative security

Fundamentals

TTM · reported
Market cap$6.60K
Enterprise value
Revenue (TTM)$1.56M
Gross profit$39.00K
EBITDA$-1.14M
Net income$-879.00K
EPS (TTM)$-0.00
Free cash flow$-1.10M
Total cash
Total debt$150.00K
Book value / share$0.00
Shares outstanding66.00M
Float64.20M
Short % of float1.20%
Dividend yield
Beta (5Y)52.46

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E0.00
PEG ratio1.07
Price / sales
Price / book0.03
EV / revenue
EV / EBITDA
Gross margin2.50%
Operating margin-658.33%
Profit margin-56.24%
Return on equity
Return on assets-58.45%
Debt / equity84.27
Current ratio0.72
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 1 year
Blank means not reported, not zero
Line item2021YoY
Total revenue $1.56M
Operating revenue $1.56M
Research & development $1.52M
Selling, general & admin $1.25M
Total operating expense $2.78M
Operating income -$1.21M
Net interest income -$200.00K
Pre-tax income -$879.00K
Tax provision $0
Net income -$879.00K
Net income to common -$879.00K
Basic EPS -0.02
Diluted EPS -0.02
EBIT -$679.00K
EBITDA -$589.00K
Basic shares 56.80M
Diluted shares 56.80M

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Mar 2017 -0.110.03 +127.3%
Dec 2016 -0.270.13 +148.1%
Sep 2016 -0.27-0.19 +28.3%
Jun 2016 -0.28-0.28 -0.0%
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter $0
Current year $0
Next year $0

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
ConsensusNONE
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders1.69%
Held by institutions0.00%
Institutions holding1
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
0.00
-9.09% from price
SMA 20
0.00
-13.04% from price
SMA 50
0.00
-68.75% from price
SMA 100
0.00
-83.16% from price
SMA 200
0.00
-88.96% from price
EMA 12
0.00
-13.14% from price
EMA 26
0.00
-41.14% from price
EMA 50
0.00
-67.18% from price
RSI (14)
37.4
Neutral
MACD (12,26,9)
-0.00
Hist 0.00
ATR (14)
0.00
14.29% of price
Realised vol 30D
567.9%
Annualised
Bollinger upper
0.00
20, 2σ
Bollinger lower
0.00
20, 2σ
50 / 200 cross
Death
0.00 vs 0.00
Trend bias
Below 200
-88.96%

Options chain

Account required
ExpirySpot 0.00
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-3.60
Less volatile than market
Correlation to SPY
-0.02
Largely independent
Realised vol 30D
567.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-99.0%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.00
14.29% of price
Beta (reported)
52.46
5Y monthly, from filing

Short interest

Semi-monthly exchange report · lags by ~2 weeks
Shares short
89.85K
Prior 76.00K
Change vs prior
+18.2%
Shorts adding
% of float
1.20%
Normal
% of shares out
0.76%
Against total outstanding
Days to cover
0.7
Liquid
Float
64.20M
Freely tradeable shares

Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.

Rating changes

4 on file
DateFirm ActionFromTo
Mar 11, 16 Roth Capital INITIATED Buy
Feb 27, 15 MLV & Co. UPGRADE Hold Buy
May 28, 14 MLV & Co. DOWNGRADE Buy Hold
Aug 14, 13 McNicoll Lewis Vlak INITIATED Buy

Dividends & splits

Declared · from the issuer
Forward rate
Forward yield
5-year avg yield
Payout ratio0.00%
Ex-dividend date
Next pay date
Last split1:5
Split dateAug 28, 2015

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.